Irbesartan/Hydrochlorothiazide Sandoz (Hydrochlorothiazide, Irbesartan)

Irbesartan/Hydrochlorothiazide is used to manage hypertension, a condition characterized by elevated arterial pressure.

• Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk.
• Hypertension with fluid retention: promotes diuresis to decrease excess extracellular fluid.
• Hypertension requiring combination therapy: provides dual mechanisms for patients not controlled on a single agent.

• Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing vasoconstriction and aldosterone‑mediated sodium retention. Hydrochlorothiazide acts on the distal convoluted tubule, inhibiting NaCl reabsorption, which increases urinary sodium and water excretion, thereby lowering plasma volume. The combined actions reduce systemic vascular resistance and blood volume, delivering an additive antihypertensive effect.

Irbesartan/Hydrochlorothiazide may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after standing.
• Headache: mild to moderate pain in the head region.
• Increased urination: more frequent need to void due to diuretic action.
• Low potassium levels: reduced serum potassium causing muscle weakness or cramps.

Serious or Rare Side Effects

• Severe dehydration: excessive fluid loss leading to hypotension.
• Acute kidney injury: sudden decline in renal function requiring monitoring.
• Allergic reactions: rash, itching, or angioedema that may need immediate medical attention.

When prescribing Irbesartan/Hydrochlorothiazide, several safety considerations should be observed.

• Blood pressure monitoring: ensure adequate control without excessive hypotension.
• Renal function assessment: evaluate creatinine and eGFR before and during therapy.
• Electrolyte surveillance: check serum potassium and sodium regularly.
• Pregnancy avoidance: drug is contraindicated in pregnancy (Category D).
• Elderly caution: start at lower dose and monitor for orthostatic effects.
• Store at room temperature: keep in the original container, protect from moisture and light.

Irbesartan/Hydrochlorothiazide can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• ACE inhibitors or ARBs: combined use may increase risk of renal impairment and hyperkalemia.
• Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): can blunt antihypertensive effect and affect renal function.

Moderate Interactions (Monitor Closely)

• Other diuretics: additive diuretic effect may lead to electrolyte disturbances.
• Beta‑blockers: additive blood‑pressure lowering may require dose adjustment.